cladribine has been researched along with Acute Lymphoid Leukemia in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (54.55) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goto, H; Goto, S; Yokosuka, T | 1 |
| Badowska, W; Balcerska, A; Balwierz, W; Czyzewski, K; Debski, R; Juraszewska, E; Konatkowska, B; Kowalczyk, J; Krawczuk-Rybak, M; Kuzmicz, M; Malinowska, I; Matysiak, M; Olejnik, I; Ploszynska, A; Sońta-Jakimczyk, D; Stanczak, E; Stefaniak, J; Styczynski, J; Szczepanski, T; Wachowiak, J; Wieczorek, M; Wysocki, M | 1 |
| Inanami, O; Kuwabara, M; Matsuda, A; Ohta, T; Takahashi, E | 1 |
| Blakley, RL; Crom, WR; Kearns, CM; Santana, VM | 1 |
| Beck, WT; Behm, FG; Blakley, RL; Campana, D; Coustan-Smith, E; Kumagai, M; Manabe, A; Raimondi, SC; Santana, VM | 1 |
| Csoka, K; de la Torre, M; Fridborg, H; Kristensen, J; Larsson, R; Liliemark, J; Nygren, P | 1 |
| Cohen, JD; Katz, TB; Marcel, PD; Strock, DJ; Teik, JE | 1 |
| Gati, WP; Paterson, AR; Wright, AM | 1 |
| Akabutu, JJ; Gati, WP; Grundy, PE; Paterson, AR; Sowa, B; Wright, AM | 1 |
| Blakley, RL; Crom, W; Kearns, C; Mirro, J; Santana, VM; Schell, MJ | 1 |
| Blakley, RL; Cherrie, J; Harwood, FC; Kalwinsky, D; Mirro, J; Santana, VM; Schell, M | 1 |
3 trial(s) available for cladribine and Acute Lymphoid Leukemia
| Article | Year |
|---|---|
Pharmacokinetics of cladribine (2-chlorodeoxyadenosine) in children with acute leukemia.
Topics: Acute Disease; Adolescent; Adult; Bilirubin; Child; Child, Preschool; Cladribine; Creatinine; Drug Administration Schedule; Female; Half-Life; Humans; Infant; Infusions, Intravenous; Kidney; Leukemia, Myeloid; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Predictive Value of Tests | 1994 |
2-Chlorodeoxyadenosine produces a high rate of complete hematologic remission in relapsed acute myeloid leukemia.
Topics: 2-Chloroadenosine; Acute Disease; Adolescent; Adult; Antineoplastic Agents; Bone Marrow Transplantation; Child; Child, Preschool; Cladribine; Combined Modality Therapy; Deoxyadenosines; Drug Evaluation; Female; Humans; Infusions, Intravenous; Leukemia, Myeloid; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Regression Analysis; Remission Induction | 1992 |
A phase I clinical trial of 2-chlorodeoxyadenosine in pediatric patients with acute leukemia.
Topics: 2-Chloroadenosine; Adolescent; Adult; Child; Child, Preschool; Cladribine; Clinical Trials as Topic; Deoxyadenosines; Dose-Response Relationship, Drug; Drug Evaluation; Female; Humans; Infant; Infusions, Intravenous; Leukemia, Myeloid; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1991 |
8 other study(ies) available for cladribine and Acute Lymphoid Leukemia
| Article | Year |
|---|---|
The combination effects of bendamustine with antimetabolites against childhood acute lymphoblastic leukemia cells.
Topics: Adenine Nucleotides; Antimetabolites; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleosides; Bendamustine Hydrochloride; Cell Line, Tumor; Cell Proliferation; Child; Cladribine; Clofarabine; Cytarabine; Drug Administration Schedule; Drug Synergism; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Vidarabine | 2016 |
In vitro sensitivity of leukemic cells to nucleoside derivatives in childhood acute leukemias: good activity in leukemic relapses.
Topics: Adolescent; Adult; Antineoplastic Agents; Cell Death; Child; Child, Preschool; Cladribine; Cytarabine; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Humans; Infant; Infant, Newborn; Leukemia, Myeloid; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Tumor Cells, Cultured; Vidarabine | 2005 |
Lipid raft disruption prevents apoptosis induced by 2-chloro-2'-deoxyadenosine (Cladribine) in leukemia cell lines.
Topics: Apoptosis; beta-Cyclodextrins; Calcium; Cell Line, Tumor; Chelating Agents; Cladribine; Drug Screening Assays, Antitumor; Egtazic Acid; Filipin; Humans; Membrane Microdomains; Nifedipine; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Time Factors | 2006 |
Use of stroma-supported cultures of leukemic cells to assess antileukemic drugs. II. Potent cytotoxicity of 2-chloro-deoxyadenosine in acute lymphoblastic leukemia.
Topics: Adolescent; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bone Marrow Cells; Carrier Proteins; Cell Death; Child; Child, Preschool; Chromosome Aberrations; Cladribine; DNA Topoisomerases, Type II; Drug Resistance; Drug Screening Assays, Antitumor; Humans; Infant; Infant, Newborn; Karyotyping; Membrane Glycoproteins; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Stromal Cells; Tumor Cells, Cultured | 1994 |
In vitro activity of 2-chlorodeoxyadenosine (CdA) in primary cultures of human haematological and solid tumours.
Topics: Adrenocortical Carcinoma; Breast Neoplasms; Cladribine; Dose-Response Relationship, Drug; Drug Resistance; Drug Screening Assays, Antitumor; Female; Humans; Kidney Neoplasms; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Lung Neoplasms; Neoplasms; Ovarian Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tumor Cells, Cultured | 1994 |
Deoxycytidine in human plasma: potential for protecting leukemic cells during chemotherapy.
Topics: Adult; Cladribine; Cytarabine; Deoxycytidine; Deoxycytosine Nucleotides; Humans; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Vidarabine | 1997 |
Enhancement of retention and cytotoxicity of 2-chlorodeoxyadenosine in cultured human leukemic lymphoblasts by nitrobenzylthioinosine, an inhibitor of equilibrative nucleoside transport.
Topics: Antineoplastic Agents; Biological Transport; Chromatography, High Pressure Liquid; Cladribine; Drug Synergism; Humans; Nucleosides; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Thioinosine; Tumor Cells, Cultured | 2000 |
Cytotoxicity of 2-chlorodeoxyadenosine and arabinosylcytosine in leukaemic lymphoblasts from paediatric patients: significance of cellular nucleoside transporter content.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Carrier Proteins; Cell Survival; Child; Cladribine; Cytarabine; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Humans; Immunophenotyping; Lymphocytes; Membrane Proteins; Nucleoside Transport Proteins; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tumor Cells, Cultured | 2002 |